Wei Hong Selected Research

Carcinogenesis

5/2017	miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.
11/2015	YAP and TAZ Take Center Stage in Cancer.
9/2015	Docosahexaenoic acid inhibits the growth of hormone-dependent prostate cancer cells by promoting the degradation of the androgen receptor.
4/2014	Sj7170, a unique dual-function peptide with a specific α-chymotrypsin inhibitory activity and a potent tumor-activating effect from scorpion venom.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Hong Research Topics

Disease

40	Neoplasms (Cancer) 07/2022 - 11/2002
17	Infections 03/2022 - 01/2011
13	Inflammation (Inflammations) 04/2021 - 08/2013
12	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2013
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2012
11	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2017
8	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2008
6	Fibrosis (Cirrhosis) 10/2021 - 04/2013
6	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 01/2016
6	Lung Neoplasms (Lung Cancer) 11/2019 - 01/2012
5	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 09/2016
5	COVID-19 01/2022 - 01/2021
5	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2010
5	Non-alcoholic Fatty Liver Disease 01/2022 - 09/2017
5	Osteoporosis 02/2021 - 01/2019
5	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 05/2007
4	Hypoxia (Hypoxemia) 07/2022 - 01/2015
4	Bacterial Infections (Bacterial Infection) 10/2021 - 09/2018
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 11/2013
4	Pathologic Processes 01/2019 - 01/2018
4	Carcinogenesis 05/2017 - 04/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2021
3	Emphysema 01/2021 - 08/2013
3	Fatigue 01/2021 - 03/2019
3	Airway Remodeling 01/2021 - 01/2017
3	Hyperlipidemias (Hyperlipidemia) 08/2020 - 12/2006
3	Ischemia 06/2018 - 06/2006
2	Pain (Aches) 03/2022 - 07/2021
2	Endometriosis 03/2022 - 12/2019
2	Diarrhea 01/2022 - 12/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 10/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2017
2	Body Weight (Weight, Body) 08/2020 - 08/2013
2	Periodontitis 02/2020 - 02/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 12/2018
2	Peritonitis 03/2019 - 09/2018
2	Hypertension (High Blood Pressure) 02/2019 - 12/2006
2	Tobacco Use Disorder (Nicotine Dependence) 01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
12	Peptides (Polypeptides)IBA 01/2021 - 01/2011
10	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2013
9	Long Noncoding RNAIBA 01/2021 - 01/2017
8	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 09/2018
8	Therapeutic UsesIBA 01/2022 - 01/2016
8	Pharmaceutical PreparationsIBA 01/2022 - 06/2015
6	Biological ProductsIBA 01/2022 - 01/2018
6	SmokeIBA 09/2021 - 08/2013
6	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2017
5	CalciumIBA 01/2021 - 01/2017
5	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2016
5	MicellesIBA 05/2020 - 11/2014
5	Messenger RNA (mRNA)IBA 12/2019 - 08/2013
4	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2011
4	EnzymesIBA 01/2022 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 04/2021 - 06/2018
4	bacitracin AIBA 03/2019 - 01/2018
4	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 05/2007
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 11/2013
3	InterleukinsIBA 09/2021 - 10/2015
3	Particulate MatterIBA 01/2021 - 01/2020
3	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2020 - 04/2013
3	Gemcitabine FDA Link 12/2019 - 06/2012
3	FlavonoidsIBA 01/2019 - 01/2017
3	AndrogensIBA 11/2018 - 05/2007
3	Docosahexaenoic AcidsIBA 11/2018 - 09/2015
3	Transcription Factors (Transcription Factor)IBA 11/2015 - 05/2010
3	Scorpion Venoms (Scorpion Venom)IBA 04/2014 - 07/2011
2	HydrogelsIBA 04/2022 - 01/2021
2	S-Adenosylmethionine (Ademetionine)IBA 01/2022 - 10/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 04/2014
2	Superoxide DismutaseIBA 01/2022 - 01/2019
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022 - 10/2011
2	InflammasomesIBA 01/2022 - 10/2015
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2010
2	QuercetinIBA 12/2021 - 01/2017
2	Anti-Infective Agents (Microbicides)IBA 10/2021 - 05/2019
2	ImmunosorbentsIBA 09/2021 - 01/2019
2	Liposomes (Liposome)IBA 04/2021 - 01/2021
2	baicalinIBA 01/2021 - 01/2021
2	Competitive Endogenous RNAIBA 01/2021 - 01/2020
2	Calcium-Sensing ReceptorsIBA 01/2021 - 01/2020
2	polyacrylamideIBA 01/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020 - 06/2018
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2020 - 02/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2012
2	ORALIT (ORS)IBA 01/2020 - 10/2019
2	Docetaxel (Taxotere)FDA Link 12/2019 - 12/2014
2	Phosphotransferases (Kinase)IBA 11/2019 - 07/2014
2	CytokinesIBA 11/2019 - 01/2017
2	RNA (Ribonucleic Acid)IBA 11/2019 - 01/2011
2	Amino Acids FDA Link 02/2019 - 06/2018

Therapy/Procedure

27	Therapeutics 07/2022 - 05/2007
12	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
6	Radiotherapy 01/2022 - 01/2016
3	Lasers (Laser) 02/2020 - 11/2014
2	Aftercare (After-Treatment) 10/2021 - 07/2020
2	Hypnosis (Mesmerism) 10/2020 - 01/2019
2	Hysterectomy 07/2020 - 11/2013
2	Electrodes (Electrode) 08/2019 - 03/2019